16 of 116 unique stocks in common · Jaccard: 13.8%
A weighted portfolio overlap of 25.95% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹25.95 is allocated to the exact same companies at the same relative proportions. The schemes share 16 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 3.56% in Aditya Birla Sun Life Value Fund and 3.95% in Tata ELSS Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in Tata |
|---|---|---|
| Reliance IndustriesPetroleum Products | 3.56% | 3.95% |
| HDFC BankBanks | 3.20% | 5.52% |
| State Bank of IndiaBanks | 2.94% | 4.36% |
| NTPCPower | 2.93% | 2.96% |
| ICICI BankBanks | 2.91% | 5.70% |
| InfosysIT - Software | 3.55% | 2.10% |
| Multi Commodity Exchange of IndiaCapital Markets | 2.79% | 1.59% |
| SBI Life Insurance CompanyInsurance | 0.93% | 1.22% |
| Ambuja CementsCement & Cement Products | 1.64% | 0.88% |
| PricolAuto Components | 0.87% | 2.09% |
| Bharat ElectronicsAerospace & Defense | 0.85% | 1.21% |
| The Federal BankBanks | 0.72% | 1.67% |
| Larsen & ToubroConstruction | 0.68% | 3.18% |
| Anant RajRealty | 0.67% | 1.15% |
| VedantaDiversified Metals | 0.78% | 0.64% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 0.48% | 1.89% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.